tiprankstipranks
Natural Alternatives International (NAII)
NASDAQ:NAII

Natural Alternatives International (NAII) Stock Price & Analysis

77 Followers

NAII Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$5.06 - $7.62
Previous Close$5.67
Volume501.00
Average Volume (3M)3.98K
Market Cap
$35.16M
Enterprise Value$75.86M
Total Cash (Recent Filing)$16.59M
Total Debt (Recent Filing)$57.30M
Price to Earnings (P/E)
Beta0.41
Sep 18, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.56
Shares Outstanding6,200,869
10 Day Avg. Volume3,286
30 Day Avg. Volume3,981
Standard Deviation0.11
R-Squared0.07
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.47
Price to Sales (P/S)0.26
Price to Cash Flow (P/CF)28.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.55
Enterprise Value/Gross Profit4.18
Enterprise Value/Ebitda-25.53
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

57.94%12.03%5.14%24.89%
57.94% Insiders
5.14% Other Institutional Investors
24.89% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

NAII FAQ

What was Natural Alternatives International’s price range in the past 12 months?
Natural Alternatives International lowest stock price was $5.06 and its highest was $7.62 in the past 12 months.
    What is Natural Alternatives International’s market cap?
    Currently, no data Available
    When is Natural Alternatives International’s upcoming earnings report date?
    Natural Alternatives International’s upcoming earnings report date is Sep 18, 2024 which is in 58 days.
      How were Natural Alternatives International’s earnings last quarter?
      Natural Alternatives International released its earnings results on May 14, 2024. The company reported -$0.269 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.269.
        Is Natural Alternatives International overvalued?
        According to Wall Street analysts Natural Alternatives International’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Natural Alternatives International pay dividends?
          Natural Alternatives International does not currently pay dividends.
          What is Natural Alternatives International’s EPS estimate?
          Natural Alternatives International’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Natural Alternatives International have?
          Natural Alternatives International has 6,200,869 shares outstanding.
            What happened to Natural Alternatives International’s price movement after its last earnings report?
            Natural Alternatives International reported an EPS of -$0.269 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 4.462%.
              Which hedge fund is a major shareholder of Natural Alternatives International?
              Currently, no hedge funds are holding shares in NAII
              ---

              Natural Alternatives International Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -19.91%
              12-Months-Change

              Fundamentals

              Return on Equity
              -3.87%
              Trailing 12-Months
              Asset Growth
              6.45%
              Trailing 12-Months

              Company Description

              Natural Alternatives International

              Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing of nutritional supplements. It operates through the following segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing. The Private Label Contract Manufacturing segment provides manufacturing services to companies that market and distribute nutritional supplements and other health care products. The Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale and use of beta-alanine. The company was founded by Mark A. LeDoux in 1980 and is headquartered in Carlsbad, CA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Natera
              USANA Health
              Radnet
              EyePoint Pharmaceuticals
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis